IAA
ABOS icon

Independent Advisor Alliance’s Acumen Pharmaceuticals ABOS Stock Holding History

Independent Advisor Alliance’s Portfolio ABOS Stock Details ABOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44.8K Hold
19,000
– – ﹤0.01% 1566
2025
Q4 		$40.1K Buy
+19,000
New +$37.7K ﹤0.01% 980

Other funds holding ABOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $421M AUM 26.25% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
KIA
Knollwood Investment Advisory Hunt Valley, Maryland $992M AUM 28.95% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

Independent Advisor Alliance's ABOS Position: Q1 2026 in Review

Independent Advisor Alliance held its Acumen Pharmaceuticals (ABOS) position steady in Q1 2026 at 19,000 shares worth $44.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1566.

Independent Advisor Alliance first reported a position in ABOS in Q4 2025 and has held it in 2 quarters since. 84 funds tracked by Wall St. Rank hold ABOS as of Q1 2026.

  • Independent Advisor Alliance held 19,000 shares of Acumen Pharmaceuticals worth $44.8K as of Q1 2026.
  • Independent Advisor Alliance left its Acumen Pharmaceuticals share count unchanged in Q1 2026.
  • Acumen Pharmaceuticals made up ﹤0.01% of Independent Advisor Alliance's portfolio in Q1 2026, its #1566 holding.
  • Independent Advisor Alliance first reported a position in Acumen Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 84 funds tracked by Wall St. Rank held Acumen Pharmaceuticals as of Q1 2026.

Based on Independent Advisor Alliance's 13F filing for Q1 2026, filed 12 May 2026.